AKT1 and Insulin resistance: Modulation of glucose and lipid metabolism by targeting the PI3K/AKT and AMPK signaling cascade may possibly provide a strategy for therapeutic intervention in the reversal of insulin resistance and potential treatment of type 2 diabetes and its complications.